IP Verse

Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods - EP2646003

The patent EP2646003 was granted to Adare Pharmaceuticals on Jun 3, 2020. The application was originally filed on Dec 2, 2011 under application number EP11845725A. The patent is currently recorded with a legal status of "Revoked".

EP2646003

ADARE PHARMACEUTICALS
Application Number
EP11845725A
Filing Date
Dec 2, 2011
Status
Revoked
Nov 19, 2021
Publication Date
Jun 3, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAFeb 23, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB -

Patent Citations (53) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20090639496
DESCRIPTIONUS20100688493
DESCRIPTIONUS20100772770
DESCRIPTIONUS20100772776
DESCRIPTIONUS2003215500
DESCRIPTIONUS2004122106
DESCRIPTIONUS2005232988
DESCRIPTIONUS2006078614
DESCRIPTIONUS2006105038
DESCRIPTIONUS2006105039
DESCRIPTIONUS2007190145
DESCRIPTIONUS2007196491
DESCRIPTIONUS2008069878
DESCRIPTIONUS2009092672
DESCRIPTIONUS2009155360
DESCRIPTIONUS2009169620
DESCRIPTIONUS2009202630
DESCRIPTIONUS2009232885
DESCRIPTIONUS2009258066
DESCRIPTIONUS2010025067
DESCRIPTIONUS2010025083
DESCRIPTIONUS4134943
DESCRIPTIONUS4305502
DESCRIPTIONUS4616047
DESCRIPTIONUS5039540
DESCRIPTIONUS5079018
DESCRIPTIONUS5178878
DESCRIPTIONUS5215756
DESCRIPTIONUS5298261
DESCRIPTIONUS5464632
DESCRIPTIONUS5466464
DESCRIPTIONUS5576014
DESCRIPTIONUS5720974
DESCRIPTIONUS5738875
DESCRIPTIONUS5843347
DESCRIPTIONUS6024981
DESCRIPTIONUS6155423
DESCRIPTIONUS6200604
DESCRIPTIONUS6311462
DESCRIPTIONUS6316026
DESCRIPTIONUS6500454
DESCRIPTIONUS6627223
DESCRIPTIONUS6663888
INTERNATIONAL-SEARCH-REPORTUS2005079138
INTERNATIONAL-SEARCH-REPORTUS2009169620
INTERNATIONAL-SEARCH-REPORTUS6569455
OPPOSITIONUS2005147670
OPPOSITIONUS2005232988
OPPOSITIONUS2009092672
OPPOSITIONUS2009169620
OPPOSITIONWO2006055142
OPPOSITIONWO2012075455
SEARCHUS2009092672

Non-Patent Literature (NPL) Citations (4) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- ARTHUR H KIBBE ED - KIBBE A H (ED), Starch, Pregelatinized, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, AMERICAN PHARMACEUTICAL ASSOC. [U.A.], WASHINGTON, DC; US, PAGE(S) 528 - 529, (20000101), ISBN 978-0-85369-381-9, XP002471274
EXAMINATION- PARIND MAHENDRAKUMAR DESAI ET AL, "Review of Disintegrants and the Disintegration Phenomena", JOURNAL OF PHARMACEUTICAL SCIENCES, US, (20160901), vol. 105, no. 9, doi:10.1016/j.xphs.2015.12.019, ISSN 0022-3549, pages 2545 - 2555, XP055607494
OPPOSITION- Larry L. Augsburger, Stephen W. Hoag, PHARMACEUTICAL DOSAGE FORMS: TABLETS Third Edition, Volume 2 : Rational Design and Formulation, CRC PRESS, (20080000), pages 2PP, 230 - 249, XP055790356
OPPOSITION- "Pharmaceutical Dosage Forms : Tablets - Unit Operations and Mechanical Properties, Chapter 8: Pharmaceutical Granulation Processes, Mechanism, and the Use of Binders", Stuart L Cantor; Augsburger Larry L; Hoag Stephen W; Gerhardt Armin, Pharmaceutical Dosage Forms : Tablets - Unit Operations and Mechanical Properties,, CRC PRESS, (20080000), pages 3PP, 283 - 284, XP055601290

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents